Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin for APDS
NCT03383380Phase 2Completed
- Sponsor
- Children's Hospital of Fudan University
- Start
- Dec 2017
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in activated phosphoinositide 3-kinase delta syndrome (APDS), sponsored by Children's Hospital of Fudan University. Started Dec 2017; status: completed.
02
Drugs
sirolimus
03
Conditions
activated phosphoinositide 3-kinase delta syndrome (APDS)
Beyond the preview
Go deeper on NCT03383380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03383380.